Sign In

Save up to 80% by drug discount in your pharmacy with "Pharmacy Near Me - National Drug Discount Card"

You can scan QR Code(just open camera on your phone/scan by application) from the image on prescription drug discount card to save it to your mobile phone. Or just click on image if you're on mobile phone.

View Generic:
View Brand:

Topcare no drip extra moisturizing - Medication Information

Product NDC Code 36800-561
Drug Name

Topcare no drip extra moisturizing

Type Brand
Pharm Class Imidazolines [CS],
Increased Sympathetic Activity [PE],
Vasoconstriction [PE],
Vasoconstrictor [EPC]
Active Ingredients
Oxymetazoline hydrochloride .05 g/100ml
Route NASAL
Dosage Form SPRAY
Application Number M012
Labeler Name Topco Associates LLC
Packages
Package NDC Code Description
36800-561-30 1 bottle, pump in 1 carton (36800-561-30) / 30 ml in 1 bottle, pump
Check if available Online

Active ingredient

A list of the active, medicinal ingredients in the drug product.
Drug Fact Active Ingredient Oxymetazoline Hydrochloride 0.05%

Dosage and administration

Information about the drug product’s dosage and administration recommendations, including starting dose, dose range, titration regimens, and any other clinically sigificant information that affects dosing recommendations.
Directions Before using for the first time, remove the protective cap form the tip and prime the pump by depressing pump firmly several times. To spray, hold bottle with thumb at base and nozzle between first and second fingers. Without tilting head, insert nozzle into nostrile. Fully depress rim with a firm and even stroke, and sniff deeply. Wipe nozzle clean after use. Adults and children 6 to under 12 years of age (with adult supervision):2 or 3 sprays in each nostril not more than every 10 to 12 hours. Do not exceed 2 doses in any 24-hour period. Children under 6 years of age consult a doctor.

Inactive ingredient

A list of inactive, non-medicinal ingredients in a drug product.
Inactive Ingredients Benzalkonium Chloride Solution, Benzyl Alcohol, Edetate Disodium, Flavor, Glycerin, Microcrystalline Cellulose and Carboxymethylcellulose Sodium, Polyethylene Glycol, Povidone, Purified Water, Sodium Phosphate Dibasic, Sodium Phosphate Monobasic

Indications and usage

A statement of each of the drug products indications for use, such as for the treatment, prevention, mitigation, cure, or diagnosis of a disease or condition, or of a manifestation of a recognized disease or condition, or for the relief of symptoms associated with a recognized disease or condition. This field may also describe any relevant limitations of use.
Uses Temporarily relieves nasal congestion due to: common cold hay fever upper respiroty allergies temporarily relieves sinus congestion and pressure Shrinks swollen membranes so you can breathe more freely

Purpose

Information about the drug product’s indications for use.
Purpose Nasal Decongestant

Spl product data elements

Usually a list of ingredients in a drug product.
TOPCARE No Drip Extra Moisturizing Oxymetazoline HCL OXYMETAZOLINE HYDROCHLORIDE OXYMETAZOLINE BENZALKONIUM CHLORIDE BENZYL ALCOHOL EDETATE DISODIUM GLYCERIN MICROCRYSTALLINE CELLULOSE CARBOXYMETHYLCELLULOSE SODIUM POLYETHYLENE GLYCOL, UNSPECIFIED WATER SODIUM PHOSPHATE, DIBASIC SODIUM PHOSPHATE, MONOBASIC

Package label principal display panel

The content of the principal display panel of the product package, usually including the product’s name, dosage forms, and other key information about the drug product.
Principal Panel -Bottle label TOPCO NDC 36800-561-30 No Drip Nasal Spray Oxymetazoline HCL 0.05%Extra Moisturizing NasaL Decongestant NET WT 1 FL.OZ (30ml) 700620L_TR_NasalSpray_ExtraMoist_1oz_Label.jpg Principal Panel -Carton label TOPCO NDC 36800-561-30 No Drip Nasal Spray Oxymetazoline HCL 0.05%Extra Moisturizing NasaL Decongestant NET WT 1 FL.OZ (30ml) 5550445_TR_NasalSpray_ExtraMoist_1oz_Crtn_.jpg

Ask doctor

Information about when a doctor should be consulted about existing conditions or sumptoms before using the drug product, including all warnings for persons with certain preexisting conditions (excluding pregnancy) and all warnings for persons experiencing certain symptoms. The warnings under this heading are those intended only for situations in which consumers should not use the product until a doctor is consulted.
Ask a Doctor before use if you have heart diease high blood pressure diabetes thyiod diease trouble urinating due to enlarged rostate gland.

Keep out of reach of children

Information pertaining to whether the product should be kept out of the reach of children, and instructions about what to do in the case of accidental contact or ingestion, if appropriate.
Keep out of the reach of children if swallowed, get medical help or contact a Poison Control Center right away.

Other safety information

Information about safe use and handling of the product that may not have been specified in another field.
Other Information store between 20° and 25°C (68° to 77°F) retain carton for future reference on full labeling

Stop use

Information about when use of the drug product should be discontinued immediately and a doctor consulted. Includes information about any signs of toxicity or other reactions that would necessitate immediately discontinuing use of the product.
stop use and ask a doctor if symptoms persist.

When using

Information about side effects that people may experience, and the substances (e.g. alcohol) or activities (e.g. operating machinery, driving a car) to avoid while using the drug product.
When using this product Do not use more than directed do not use for more than three days, Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen. temporary discomfort such as burning ,stinging, sneezing or an increase in nasal discharge may occur. use of this container by more than one person may spread infection.

Pregnancy

Information about effects the drug may have on pregnant women or on a fetus. This field may be ommitted if the drug is not absorbed systemically and the drug is not known to have a potential for indirect harm to the fetus. It may contain information about the established pregnancy category classification for the drug. (That information is nominally listed in the teratogenic_effects field, but may be listed here instead.)
if pregnant or breast-feeding ask a health professional before use.

Warnings

Information about serious adverse reactions and potential safety hazards, including limitations in use imposed by those hazards and steps that should be taken if they occur.
Warnings

Disclaimer: Do not rely on openFDA or Phanrmacy Near Me to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Source: OpenFDA, Healthporta Drugs API